1. Home
  2. GTX vs NTLA Comparison

GTX vs NTLA Comparison

Compare GTX & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTX
  • NTLA
  • Stock Information
  • Founded
  • GTX 2018
  • NTLA 2014
  • Country
  • GTX Switzerland
  • NTLA United States
  • Employees
  • GTX N/A
  • NTLA N/A
  • Industry
  • GTX Auto Parts:O.E.M.
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • GTX Consumer Discretionary
  • NTLA Health Care
  • Exchange
  • GTX Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • GTX 1.8B
  • NTLA 1.5B
  • IPO Year
  • GTX N/A
  • NTLA 2016
  • Fundamental
  • Price
  • GTX $8.31
  • NTLA $14.30
  • Analyst Decision
  • GTX Strong Buy
  • NTLA Buy
  • Analyst Count
  • GTX 1
  • NTLA 17
  • Target Price
  • GTX $12.00
  • NTLA $56.63
  • AVG Volume (30 Days)
  • GTX 869.0K
  • NTLA 3.1M
  • Earning Date
  • GTX 10-24-2024
  • NTLA 11-07-2024
  • Dividend Yield
  • GTX N/A
  • NTLA N/A
  • EPS Growth
  • GTX N/A
  • NTLA N/A
  • EPS
  • GTX 1.01
  • NTLA N/A
  • Revenue
  • GTX $3,576,000,000.00
  • NTLA $43,086,000.00
  • Revenue This Year
  • GTX N/A
  • NTLA $50.73
  • Revenue Next Year
  • GTX $3.10
  • NTLA $8.69
  • P/E Ratio
  • GTX $8.21
  • NTLA N/A
  • Revenue Growth
  • GTX N/A
  • NTLA N/A
  • 52 Week Low
  • GTX $7.13
  • NTLA $12.82
  • 52 Week High
  • GTX $10.16
  • NTLA $34.87
  • Technical
  • Relative Strength Index (RSI)
  • GTX 63.40
  • NTLA 39.75
  • Support Level
  • GTX $7.72
  • NTLA $12.82
  • Resistance Level
  • GTX $8.13
  • NTLA $17.30
  • Average True Range (ATR)
  • GTX 0.24
  • NTLA 1.13
  • MACD
  • GTX 0.07
  • NTLA -0.05
  • Stochastic Oscillator
  • GTX 89.72
  • NTLA 29.54

About GTX Garrett Motion Inc.

Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: